Somalogic Launches Validation Studies of Protein Biomarkers for Pancreatic Cancer and Mesothelioma
Filed in Mesothelioma News on Oct.15, 2010
Clinical proteomics firm Somalogic has begun validation of its protein biomarker-based diagnostics for pancreatic cancer and mesothelioma.
View full post on mesothelioma – Yahoo! News Search Results
Tags: Biomarkers, Cancer, launches, Mesothelioma, pancreatic, Protein, Somalogic, Studies, Validation

Leave a Reply
You must be logged in to post a comment.